Cargando…

Nebivolol for improving endothelial dysfunction in cardiac syndrome-x; Is it ready for clinical use?

Detalles Bibliográficos
Autor principal:	Fatahian, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073798/ https://www.ncbi.nlm.nih.gov/pubmed/32206074 http://dx.doi.org/10.22122/arya.v15i6.1971

Ejemplares similares

Nebivolol: impact on cardiac and endothelial function and clinical utility
por: Toblli, Jorge Eduardo, et al.
Publicado: (2012)

Botulinum Toxin Injection into Epicardial Fat Pads: A Promising Potential Modality for Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery
por: Fatahian, Alireza
Publicado: (2019)

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension
por: Li, Bingwei, et al.
Publicado: (2020)

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
por: Schmidt, André C, et al.
Publicado: (2008)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure
por: Stauffer, Brian L., et al.
Publicado: (2017)

Studies directed toward the exploitation of vicinal diols in the synthesis of (+)-nebivolol intermediates
por: Devi, Runjun, et al.
Publicado: (2017)

Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X
por: Majidinia, Maryam, et al.
Publicado: (2016)

Nebivolol: A unique drug in acute and chronic renal disorders
por: Amiri, Fateme Shamekhi
Publicado: (2015)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

A Review of Nebivolol Pharmacology and Clinical Evidence
por: Fongemie, Justin, et al.
Publicado: (2015)

Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome
por: Mercanoglu, Guldem, et al.
Publicado: (2019)

A case report of a rare cardiac complication in novel coronavirus disease
por: Malekrah, Alireza, et al.
Publicado: (2020)

Effects of Nebivolol on Endothelial Function and Exercise Parameters in Patients with Slow Coronary Flow
por: Tiryakioglu, Selma, et al.
Publicado: (2009)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

Arterial stiffness, hypertension, and rational use of nebivolol
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2009)

Effects of Nebivolol on Endothelial Gene Expression during Oxidative Stress in Human Umbilical Vein Endothelial Cells
por: Garbin, Ulisse, et al.
Publicado: (2008)

Association of endothelial dysfunction and cytotoxin-associated gene A-positive Helicobacter pylori in patients with cardiac syndrome X
por: Rasmi, Yousef, et al.
Publicado: (2016)

Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft
por: Cerit, Levent
Publicado: (2016)

Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells
por: Antoine, Marie-Hélène, et al.
Publicado: (2022)

Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Rhabdomyolysis in a patient taking nebivolol
por: Kim, Ye Jin, et al.
Publicado: (2016)

Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues from Young Rats
por: Pullen, Candice, et al.
Publicado: (2014)

Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and Nebivolol
por: Gul, Rukhsana, et al.
Publicado: (2015)

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure
por: Del Sindaco, Donatella, et al.
Publicado: (2010)

Nebivolol therapy improves QTc and QTcd parameters in heart failure patients
por: Aksoy, SM, et al.
Publicado: (2012)

The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells
por: Mason, R Preston, et al.
Publicado: (2013)

Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X
por: Long, Ming, et al.
Publicado: (2017)

Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLC
por: Kokil, S. U., et al.
Publicado: (2009)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
por: Giles, Thomas D., et al.
Publicado: (2017)

Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction
por: Ozaydin, Mehmet, et al.
Publicado: (2016)

Comparison of Nebivolol and Bisoprolol for Cardiovascular Mortality in Hypertensive Patients
por: Kumar, Ratan, et al.
Publicado: (2019)

Formulation and Evaluation of S-(-)-Amlodipine Besylate and Nebivolol Hydrochloride Tablets
por: Shaikh, S.A, et al.
Publicado: (2010)

Development and In vitro Evaluation of Mucoadhesive Buccal Films of Nebivolol
por: Mane, P. P., et al.
Publicado: (2014)

Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers
por: BRICIU, CORINA, et al.
Publicado: (2015)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018)

Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
por: Mohamed, Enas Ahmed, et al.
Publicado: (2018)

Data of Nebivolol on oxidative stress parameters in hypertensive patients
por: Barroso, Helena C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ferac29l21jj80q0rfgqh6as1